Chemiesynth (Vapi) Ltd (CHEMIESYNT) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Chemiesynth (Vapi) Ltd on NSE and BSE, with an AI summary of each filing.
submission of the Unaudited standalone financial result for the quarter and half year ended September 30, 2026
Financial Result · 04 Nov 2026, 8:37 pm
Chemiesynth (Vapi) Reports Q2 FY27 Results with Narrowed Net Loss Chemiesynth (Vapi) reported standalone revenue from operations of ₹531.98 lakh for the quarter ended 30th Sep'26, down 22.59% YoY from ₹687.15 lakh but up 26.76% QoQ from ₹419.69 lakh. Total income stood at ₹538.62 lakh. Net loss narrowed to ₹15.89 lakh compared to ₹43.95 lakh in Q2 FY26 and ₹58.37 lakh in Q1 FY27, with basic EPS at ₹-0.52. For H1 ended 30th Sep'26, revenue stood at ₹951.67 lakh with a net loss of ₹74.26 lakh. Total debt increased to ₹1,791.77 lakh.
outcome of the board meeting held on 04th November, 2026
Outcome · 04 Nov 2026, 8:28 pm
Chemiesynth (Vapi) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 532 (-22.6% YoY | +26.8% QoQ) ■ EBITDA: 42.4 (+128.3% YoY | +992.5% QoQ) ■ EBITDA Margin (%): 8.0 (+527 bps YoY | +704 bps QoQ) ■ PAT: -15.9 (+63.8% YoY | +72.8% QoQ) ■ EPS (INR): -0.52 (+63.6% YoY | +72.6% QoQ)
Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the unaudited financial ....
Intimation · 04 Nov 2026, 5:30 am
Chemiesynth (Vapi) Schedules Board Meeting for Q2 FY27 Results Chemiesynth (Vapi) Limited has scheduled its Board of Directors meeting for 4th Nov'26 to consider, approve, and take on record the company's un-audited financial results along with the limited review report for the quarter and half-year ended 30th Sep'26. Additionally, per SEBI insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the formal declaration of the financial results.
Pursuant to regulation 30 of SEBI (LODR) board has considered & approved the allotment of unlisted Non covariable cumulative redeemable preference share (NCRPS) on a private placement basis.
Others (Uncategorized) · 28 Oct 2026, 5:39 pm
Chemiesynth (Vapi) Approves ₹10 Crore Unlisted Preference Share Allotment Chemiesynth (Vapi) Limited’s Board approved the private placement allotment of 1.00 crore unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) under Tranche 1 on 28th Oct'26. Issued at a face value and price of ₹10 per share, the total issue size stands at ₹10.00 crore. The unsecured instrument carries a 5% cumulative annual dividend and a 7-year tenure maturing on 28th Oct'33, with company call and investor put options exercisable after two years subject to a 30-day notice period.
Outcome of Board Meeting held on 28.10.2026 regarding Allotment of unlisted NCRPS under the First Tranche
Outcome · 28 Oct 2026, 5:35 pm
Chemiesynth Vapi Approves Allotment of ₹10 Crore Unlisted NCRPS Chemiesynth Vapi Limited's Board approved the private placement allotment of 1.00 crore unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) under its First Tranche on 28th Oct'26. Issued at par with a face value of ₹10 per share, the aggregate issue size stands at ₹10.00 crore. The unsecured instrument carries a 5% cumulative annual dividend and matures in 7 years on 28th Oct'33. Both company call and investor put options are exercisable after 2 years with a 30-day notice period.
Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the allotment of unlisted ....
Intimation · 23 Oct 2026, 4:48 pm
Chemiesynth (Vapi) Board to Consider Unlisted NCRPS Allotment Chemiesynth (Vapi) Limited has scheduled a Board of Directors meeting on 28th Oct'26 to consider and approve the allotment of unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis. The board will also consider and authorize related statutory filings, corporate actions, and other consequential matters connected to the proposed preference share issuance.
submission of e-voting and scrutinizer''s report of 40th Annual General Meeting held on 30th September 2026 at registered office of the company.
Annual General Meeting · 30 Sept 2026, 7:19 pm
outcome of the 40th Annual General Meeting of the company held on 30th September 2026 at registered office of the company
Annual General Meeting · 30 Sept 2026, 5:47 pm
outcome of the 40th Annual General Meeting of the company held on 30th September 2026 at registered office of the company
Annual General Meeting · 30 Sept 2026, 5:46 pm
Outcome of the 40th Annual General Meeting of the company held on Wednesday, 30th September 2026 at 11:00 AM at the registered office of the company
Annual General Meeting · 30 Sept 2026, 5:33 pm
attached the letter of weblink sent to the shareholder
Others (Uncategorized) · 03 Sept 2026, 6:31 pm
Chemiesynth (Vapi) Ltd Schedules 40th AGM for September 2026 and Releases FY26 Annual Report Chemiesynth (Vapi) Limited scheduled its 40th AGM for 30th Sep'26. The company dispatched communications providing web links for the FY25-26 Annual Report to shareholders without registered emails, utilizing a cut-off date of 23rd Sep'26. Management also issued a statutory reminder for physical shareholders to update mandatory KYC details, including PAN and bank account mandates, per SEBI guidelines. This update is strictly required to ensure continued eligibility for electronic dividend, interest, or redemption payments.
Annual Report for the FY 2025-26
Others (Uncategorized) · 03 Sept 2026, 6:21 pm
Intimation of Notice of 40th Annual general meeting of the member of the company to be held on 30th September, 2026 at 11:00 am at registered office of the company
Annual General Meeting · 03 Sept 2026, 6:15 pm
with reference to the outcome of board meeting held on 12th August 2026. we hereby submit corrigendum to rectify a typographical error in book closure date and benpose date
Outcome · 13 Aug 2026, 10:11 pm
Chemiesynth Corrects AGM Book Closure and Benpose Dates Chemiesynth (VAPI) Limited has issued a corrigendum to correct dates announced after its 12th Aug'26 board meeting. The Share Transfer Book Closure period for the 40th Annual General Meeting has been revised to 24th Sep'26 to 30th Sep'26, from the previously stated 23rd Sep'25 to 30th Sep'25. Additionally, the Benpose Date for sending the AGM notice has been corrected to 28th Aug'26, instead of 29th Aug'26. All other details from the original board meeting outcome remain unchanged.
Submission of standalone Unaudited Financial Results for the first quarter ended on 30.06.2026
Financial Result · 12 Aug 2026, 9:41 pm
Chemiesynth Q1FY27 Loss Widens; Board Approves ₹15cr Preference Share Issue Chemiesynth (Vapi) Ltd. reported a wider loss for Q1FY27 ended Jun'26. Net Loss stood at ₹58.37 lakh compared to a loss of ₹45.63 lakh YoY, as total income fell 23.6% QoQ to ₹421.55 lakh. On 12th Aug'26, the board approved a ₹15cr issuance of Unlisted 5% Non-Convertible Cumulative Redeemable Preference Shares on a private placement basis. The board also approved increasing the authorized share capital from ₹3.25cr to ₹18.25cr. The 40th AGM is scheduled for 30th Sep'26.
Submission of standalone Unaudited Financial Results for the first quarter ended on 30.06.2026
Financial Result · 12 Aug 2026, 9:40 pm
Chemiesynth Q1FY27 Results & Capital Raising Plans Chemiesynth (Vapi) reported a net loss of ₹58.37 lakh for Q1 ended 30th Jun'26, compared to a loss of ₹45.63 lakh YoY and a profit of ₹60.36 lakh QoQ. Revenue from operations stood at ₹419.69 lakh, a 5.6% YoY increase but a 23.7% QoQ decline. The Board also approved raising authorized share capital from ₹3.25 Cr to ₹18.25 Cr and issuing up to ₹15 Cr in unlisted non-convertible preference shares on a private placement basis. The 40th AGM is scheduled for 30th Sep'26.
as per attachment
Outcome · 12 Aug 2026, 9:33 pm
Chemiesynth (Vapi) Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 420 (+5.6% YoY | -23.7% QoQ) ■ EBITDA: 3.9 (-79.0% YoY | -96.3% QoQ) ■ EBITDA Margin (%): 0.9 (-372 bps YoY | -1802 bps QoQ) ■ PAT: -58.4 (-27.9% YoY | Profit to Loss QoQ) ■ EPS (INR): -1.90 (-27.5% YoY | Profit to Loss QoQ)
Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Standalone Unaudited Financial ....
Intimation · 12 Aug 2026, 5:30 am
Audited Financial Results along with Auditor''s Report for the Quarter & Year ended 31.03.2026
Financial Result · 27 May 2026, 10:32 pm
Chemiesynth (Vapi) reports Q4 & FY26 results with an unmodified audit opinion Chemiesynth (Vapi) reported audited results for Q4FY26, posting a Profit After Tax of ₹60.36 lakh, a significant turnaround from a loss of ₹69.71 lakh in Q3FY26 and a profit of ₹18.86 lakh in Q4FY25. Revenue from operations for the quarter stood at ₹550.25 lakh, down 17.7% YoY. For the full year FY26, the company recorded a net loss of ₹98.93 lakh on revenues of ₹2,143.52 lakh. The statutory auditor, M/s Manoj Shah & Co, issued an unmodified opinion on the results.
outcome of the meeting of the Board of director held on held on 27th May 2026
Outcome · 27 May 2026, 10:25 pm
Chemiesynth (Vapi) Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 550 (-17.7% YoY | +8.2% QoQ) ■ EBITDA: 104 (+29.6% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 18.9 (+691 bps YoY | Loss to Profit QoQ) ■ PAT: 60.4 (+220.0% YoY | Loss to Profit QoQ) ■ EPS (INR): 1.97 (+223.0% YoY | Loss to Profit QoQ)
Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Intimation · 27 May 2026, 5:30 am
Chemiesynth Board Meeting on 27th May'26 to Approve Q4 & FY26 Results Chemiesynth (Vapi) Limited's Board of Directors will meet on 27th May'26 to consider and approve the audited financial results for the quarter and financial year ended 31st Mar'26. In accordance with SEBI regulations, the trading window for insiders has been closed since 01st Apr'26 and will reopen 48 hours after the declaration of the financial results. The company will publish the results on its website and in newspapers.
The compliance letter of statement of deviation under Regulation 32(1) of SEBI LODR is filed for taking on record.
Others (Uncategorized) · 22 Apr 2026, 6:01 pm
Chemiesynth Confirms No Deviation in Use of Proceeds for Q4 FY26 Chemiesynth (Vapi) Limited confirmed on 22 Apr'26 there was no deviation or variation in the use of proceeds for the quarter and year ended 31 Mar'26. The company stated it has not raised any funds from the public, such as through a rights issue. Consequently, the requirement for a statement on the utilization of funds is not applicable for the period, as per its filing under Regulation 32 of SEBI (LODR) Regulations 2015.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 15 Apr 2026, 4:44 pm
Chemiesynth Not Classified as a Large Corporate for FY26 Chemiesynth (Vapi) Ltd. has formally notified the BSE that it does not meet the criteria to be classified as a Large Corporate for the financial year ending 31 Mar'26. This assessment is based on SEBI's circular (SEBI/HO/DDHS/CIR/P/2018/144) concerning fundraising via debt securities. Consequently, the company is not required to make the mandated annual disclosures under this framework. The company also declared that it is not a Large Corporate in its initial disclosure, citing outstanding borrowings of just ₹9.07 Cr.
Appointment of Internal Auditor for the Financial Year 2025-26 & 2026-27.
Others (Uncategorized) · 25 Mar 2026, 6:21 pm
Chemiesynth (Vapi) Appoints New Internal Auditor for FY26-27 Chemiesynth (Vapi) Limited's Board of Directors, in its meeting on 25-Mar'26, approved the appointment of M/s Purvi Gandhi & Associates, Chartered Accountant, as the company's Internal Auditor. The appointment is for the financial years 2025-26 and 2026-27. Remuneration will be mutually agreed upon between the auditor and the Board. This action is in compliance with SEBI's Listing Obligations and Disclosure Requirements regulations.
Disclosure under regulation 30 of SEBI (LODR) Regulation, 2015 -appointment of Internal Auditor for the financial year 2025-26 & 2026-27
Change in Auditor · 25 Mar 2026, 5:53 pm
Chemiesynth Appoints Internal Auditor for FY26 and FY27 Chemiesynth (Vapi) Limited's board approved the appointment of M/s Purvi Gandhi & Associates (Reg. No. 145052W) as the company's Internal Auditor on 25 Mar'26. The appointment covers the financial years 2025-26 and 2026-27. The terms of engagement, including scope, methodology, and remuneration, have been approved following consultation with the Audit Committee.